|
|
|
Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time.
Sign up now!
Already registered? Please sign in.
Alternatively, please use our pay-per-view service. |
|
|
 |
Industry Events |
 |
Formulation and Drug Delivery Series UK
8-9 July 2020, Oxford Global
This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >> |
|
 |
News and Press Releases |
 |
Avacta develops SARS-COV-2 neutralising Affimer reagents with therapeutic potential for COVID-19
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics
and reagents, is pleased to announce that several of the Affimer
reagents recently generated for development of a point-of-care COVID-19
antigen saliva test have now also been shown to block the interaction
between the virus’ spike protein and ACE2, a receptor on human cells
that is key to the virus infection pathway1.
More info >> |
|
|
